Please login to the form below

Not currently logged in
Email:
Password:

Dr Reddy's makes senior changes as US generics head exits

UmangVohra will be replaced by Alok Sonig

Dr Reddy's Umang VohraDr Reddy's has appointed Alok Sonig to be its new head of North America generics to take over from Umang Vohra (pictured).

Vohra is leaving the Indian generics-focused company after nearly three years as its executive VP and head North America Generics.

In total he spent 13 years with the firm, which he joined in 2002 from Pepsico-India, where he was financial planning manager.

Vohra's replacement at Dr Reddy's is the company's head of India generics Alok Sonig who, prior to joining the firm, served at Bristol-Myers Squibb, where he spent three years as managing director of BMS India.

To fill Sonig's vacant role Dr Reddy's has handed MV Ramana, currently executive vice president - emerging markets, additional responsibilities with a move to executive vice president and head branded markets (India and emerging countries).

1st September 2015

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Anthill Agency

Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....

Infographics